A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: hold back (279), keep back (403), deny (12)

Lenvatinib(60kg or greater)

Description
Chemotherapy Protocol HEPATOCELLULAR CANCER LENVATINIB (60kg or greater) Regimen • Hepatocellular – Lenvatinib Indication • Lenvatinib is indicated where either
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Hepatobiliary/Lenvatinib-60kg-or-greater-Ver1.pdf

Lenvatinib(59kg or less)

Description
Chemotherapy Protocol HEPATOCELLULAR CANCER LENVATINIB (59kg or less) Regimen • Hepatocellular – Lenvatinib Indication • Lenvatinib is indicated where either; -
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Hepatobiliary/Lenvatinib-59kg-or-less-.pdf

VR-RituximabVenetoclax Cycle_2 Onwards

Description
Chemotherapy Protocol Chronic Lymphocytic Leukaemia VR-RITUXIMAB-VENETOCLAX (high risk) (Cycle 2 onwards) Regimen • CLL – VR Rituximab Venetoclax (high risk) Cycle
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/VR-RituximabVenetoclax-Cycle-2-Onwards.pdf

Bendamustine_90_RituximabSplit

Description
Chemotherapy Protocol CHRONIC LYMPHOCYTIC LEUKAEMIA BENDAMUSTINE (90)-RITUXIMAB (Split) There are multiple versions of this protocol in use that vary depending
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Bendamustine-90-RituximabSplit.pdf

Bendamustine_90_Rituximab

Description
Chemotherapy Protocol CHRONIC LYMPHOCYTIC LEUKAEMIA BENDAMUSTINE (90)-RITUXIMAB There are multiple versions of this protocol in use that vary depending on
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Bendamustine-90-Rituximab.pdf

Bendamustine_70_RituximabSplit

Description
Chemotherapy Protocol CHRONIC LYMPHOCYTIC LEUKAEMIA BENDAMUSTINE (70)-RITUXIMAB (Split) This protocol may require funding There are multiple versions of this protocol
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Bendamustine-70-RituximabSplit.pdf

Bendamustine_70_Rituximab

Description
Chemotherapy Protocol CHRONIC LYMPHOCYTIC LEUKAEMIA BENDAMUSTINE (70)-RITUXIMAB There are multiple versions of this protocol in use that vary depending on
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Bendamustine-70-Rituximab.pdf

Acalabrutinib

Description
Chemotherapy Protocol Chronic Lymphocytic Leukaemia Regimen Acalabrutinib • CLL – Acalabrutinib Indication • First-line treatment of chronic lymphocytic leukaemia (CLL) prior to EU
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Acalabrutinib.pdf

Cetuximab-Irinotecan (21day)

Description
Chemotherapy Protocol COLORECTAL CANCER CETUXIMAB-IRINOTECAN (21 day) This regimen may require funding Regimen • Colorectal Cancer–Cetuximab-Irinotecan (21 day) Indication
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Cetuximab-Irinotecan.pdf

Bevacizumab-Capecitabine-Oxaliplatin

Description
Chemotherapy Protocol COLORECTAL CANCER BEVACIZUMAB-CAPECITABINE-OXALIPLATIN This protocol may require funding Regimen
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Bevacizumab-Capecitabine-Oxaliplatin.pdf
181 to 190 of 211
Previous … 17 18 19 20 21 … Next